Aerosol bolus dispersion in healthy and asthmatic children-theoretical and experimental results

Robert Sturm1

  • 1Brunnleitenweg 41, A-5061 Elsbethen, Salzburg, Austria.

Insights

Aerosol bolus dispersion increases exponentially with lung depth in children. Asthmatic children show greater dispersion than healthy children, suggesting limited diagnostic potential for aerosol bolus inhalation.

Area of Science:

  • Pulmonary medicine
  • Respiratory physiology
  • Medical physics

Background:

  • Aerosol bolus inhalation is a non-invasive technique for diagnosing lung diseases.
  • Theoretical models of aerosol bolus behavior are crucial for understanding lung function.
  • This study focuses on aerosol bolus dispersion in healthy and asthmatic children.

Purpose of the Study:

  • To theoretically investigate aerosol bolus dispersion in healthy and asthmatic children.
  • To validate model predictions with experimental findings.
  • To assess the diagnostic potential of aerosol bolus inhalation.

Main Methods:

  • Simulated aerosol bolus transport using a stochastic respiratory tract model.
  • Scaled models for healthy and asthmatic pediatric lungs.
  • Utilized effective diffusivities (Deff) for convective mixing prediction.
  • Inhaled monodisperse particles (0.4 µm diameter).
  • Varied volumetric lung depth (95-540 mL) and bolus half-width (50 mL).

Main Results:

  • Aerosol bolus dispersion increases exponentially with volumetric lung depth in both groups.
  • Asthmatic children exhibit higher bolus dispersion than healthy children, especially at depths <300 mL.
  • Skewness decreases with increasing lung depth, with higher values in asthmatics.
  • Model predictions show strong agreement with experimental data.

Conclusions:

  • Theoretical models accurately approximate experimental aerosol bolus study results.
  • Aerosol bolus inhalation and dispersion measurements have limited diagnostic value for lung diseases.
  • Further research may refine the understanding of aerosol dispersion in pediatric respiratory conditions.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.6K
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
22
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
1.1K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
26